APA (7th ed.) Citation

M, G., N, B., B, S., M, G., & J, C. (2025). Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): An observational study protocol. Lupus science & medicine, 12(1), . https://doi.org/10.1136/lupus-2024-001486

Chicago Style (17th ed.) Citation

M, Galindo-Izquierdo, Bahamontes-Rosa N, Sarto-Ferres B, Galvez-Fernandez M, and Cortés-Hernández J. "Characteristics and Clinical Outcomes of Patients with Systemic Lupus Erythematosus Initiating Anifrolumab in a Real-world Setting in Spain (AZAHAR Study): An Observational Study Protocol." Lupus Science & Medicine 12, no. 1 (2025). https://doi.org/10.1136/lupus-2024-001486.

MLA (9th ed.) Citation

M, Galindo-Izquierdo, et al. "Characteristics and Clinical Outcomes of Patients with Systemic Lupus Erythematosus Initiating Anifrolumab in a Real-world Setting in Spain (AZAHAR Study): An Observational Study Protocol." Lupus Science & Medicine, vol. 12, no. 1, 2025, https://doi.org/10.1136/lupus-2024-001486.